Signaturefd, LLC Genmab A/S Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Genmab A/S stock. As of the latest transaction made, Signaturefd, LLC holds 7,900 shares of GMAB stock, worth $162,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,900

Previous 5,980 32.11%

Holding current value

$162,661

Previous $150,000 28.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$23.84 - $28.48 $45,772 - $54,681	1,920 Added 32.11%	7,900 $192,000
Q2 2024 Jul 29, 2024	SELL	$25.13 - $30.27 $103,259 - $124,379	-4,109 Reduced 40.73%	5,980 $150,000
Q1 2024 May 03, 2024	SELL	$26.43 - $32.77 $64,700 - $80,220	-2,448 Reduced 19.53%	10,089 $301,000
Q4 2023 Jan 31, 2024	SELL	$27.94 - $35.44 $123,774 - $156,999	-4,430 Reduced 26.11%	12,537 $399,000
Q3 2023 Nov 03, 2023	BUY	$35.27 - $42.24 $63,486 - $76,032	1,800 Added 11.87%	16,967 $598,000
Q2 2023 Aug 01, 2023	BUY	$37.4 - $42.94 $51,612 - $59,257	1,380 Added 10.01%	15,167 $576,000
Q1 2023 Apr 28, 2023	SELL	$34.88 - $43.22 $36,275 - $44,948	-1,040 Reduced 7.01%	13,787 $520,000
Q4 2022 Jan 27, 2023	BUY	$33.8 - $47.06 $55,769 - $77,649	1,650 Added 12.52%	14,827 $628,000
Q3 2022 Nov 08, 2022	BUY	$31.52 - $373.61 $126,300 - $1.5 Million	4,007 Added 43.7%	13,177 $423,000
Q2 2022 Aug 10, 2022	SELL	$26.83 - $38.57 $9,497 - $13,653	-354 Reduced 3.72%	9,170 $298,000
Q1 2022 May 02, 2022	SELL	$30.95 - $39.68 $5,292 - $6,785	-171 Reduced 1.76%	9,524 $345,000
Q4 2021 Jan 25, 2022	BUY	$35.87 - $47.12 $26,220 - $34,444	731 Added 8.15%	9,695 $384,000
Q3 2021 Oct 28, 2021	BUY	$41.55 - $48.72 $37,685 - $44,189	907 Added 11.26%	8,964 $392,000
Q2 2021 Jul 26, 2021	SELL	$32.88 - $44.57 $7,398 - $10,028	-225 Reduced 2.72%	8,057 $329,000
Q1 2021 Apr 30, 2021	BUY	$30.92 - $44.4 $31,816 - $45,687	1,029 Added 14.19%	8,282 $272,000
Q4 2020 Feb 11, 2021	SELL	$33.66 - $40.76 $572 - $692	-17 Reduced 0.23%	7,253 $295,000
Q3 2020 Nov 03, 2020	BUY	$33.07 - $38.68 $120,242 - $140,640	3,636 Added 100.06%	7,270 $266,000
Q2 2020 Jul 30, 2020	BUY	$20.05 - $33.89 $9,684 - $16,368	483 Added 15.33%	3,634 $123,000
Q1 2020 Apr 23, 2020	SELL	$17.15 - $25.22 $22,963 - $33,769	-1,339 Reduced 29.82%	3,151 $67,000
Q4 2019 Feb 05, 2020	BUY	$18.88 - $24.14 $39,836 - $50,935	2,110 Added 88.66%	4,490 $100,000
Q3 2019 Oct 16, 2019	BUY	$18.0 - $21.38 $42,840 - $50,884	2,380 New	2,380 $48,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account